1.10
price down icon2.65%   -0.03
after-market アフターアワーズ: 1.08 -0.02 -1.82%
loading

Eyenovia Inc (EYEN) 最新ニュース

pulisher
06:50 AM

Eyenovia Delays Yearly Report Filing - TipRanks

06:50 AM
pulisher
Mar 26, 2025

Deal Watch: Eyenovia Looks At New Direction In Proposed Merger With Betaliq - insights.citeline.com

Mar 26, 2025
pulisher
Mar 25, 2025

Eyenovia Inc expected to post a loss of $7.20 a shareEarnings Preview - TradingView

Mar 25, 2025
pulisher
Mar 21, 2025

Eyenovia falls on plans to seek reverse merger - MSN

Mar 21, 2025
pulisher
Mar 21, 2025

Eyenovia Enters Into Non-Binding Letter of Intent to Effect Reverse Merger With Betaliq - VisionMonday.com

Mar 21, 2025
pulisher
Mar 20, 2025

Eyenovia And Betaliq Announce Potential Reverse Merger - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Eyenovia Shares Drop 14% Amid Betaliq Merger Talks - Yahoo Finance

Mar 20, 2025
pulisher
Mar 20, 2025

Eyenovia stock falls on reverse merger plans (EYEN:NASDAQ) - Seeking Alpha

Mar 20, 2025
pulisher
Mar 20, 2025

Eyenovia falls after plans to merge with private firm Betaliq - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Eyenovia Plans All-Stock Reverse Merger With Betaliq - MarketWatch

Mar 20, 2025
pulisher
Mar 20, 2025

Eyenovia and Betaliq Explore Merger to Form New Ophthalmic Company Combining Innovative Drug Delivery Technologies for Glaucoma Treatment - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq - GlobeNewswire

Mar 20, 2025
pulisher
Mar 20, 2025

Strategic Merger Alert: Eyenovia and Betaliq Join Forces to Revolutionize Eye Care Delivery - StockTitan

Mar 20, 2025
pulisher
Mar 15, 2025

EYENOVIA Earnings Preview: Recent $EYEN Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 15, 2025
pulisher
Mar 07, 2025

Eyenovia, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Feb 28, 2025

Eyenovia regains compliance with Nasdaq - MSN

Feb 28, 2025
pulisher
Feb 27, 2025

Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements - GlobeNewswire

Feb 27, 2025
pulisher
Feb 26, 2025

Eyenovia Shares Surge After Regaining Nasdaq Compliance: What's Going On? - Benzinga

Feb 26, 2025
pulisher
Feb 26, 2025

Eyenovia regains Nasdaq compliance, eyes strategic options By Investing.com - Investing.com Canada

Feb 26, 2025
pulisher
Feb 26, 2025

Eyenovia regains Nasdaq compliance, eyes strategic options - Investing.com India

Feb 26, 2025
pulisher
Feb 26, 2025

Eyenovia shareholders approve reverse stock split and additional stock reserve - MSN

Feb 26, 2025
pulisher
Feb 26, 2025

Eyenovia Escapes Delisting Threat: What's Next for the Optejet Developer? - StockTitan

Feb 26, 2025
pulisher
Feb 26, 2025

Eyenovia regains Nasdaq compliance with stock bid price By Investing.com - Investing.com Australia

Feb 26, 2025
pulisher
Feb 25, 2025

Eyenovia regains Nasdaq compliance with stock bid price - Investing.com

Feb 25, 2025
pulisher
Feb 25, 2025

Eyenovia, Inc. Announces Debt Restructuring, Including Amendment to Senior Secured Debt to Improve Liquidity - Vision Monday

Feb 25, 2025
pulisher
Feb 24, 2025

Eyenovia defers debt payments to bolster liquidity By Investing.com - Investing.com Nigeria

Feb 24, 2025
pulisher
Feb 24, 2025

Eyenovia announces debt restructuring, improving cash runway - MSN

Feb 24, 2025
pulisher
Feb 24, 2025

Eyenovia, Inc. Announces Debt Restructuring Including - GlobeNewswire

Feb 24, 2025
pulisher
Feb 24, 2025

Eyenovia defers loan payments, may convert debt to equity By Investing.com - Investing.com Canada

Feb 24, 2025
pulisher
Feb 24, 2025

Eyenovia defers loan payments, may convert debt to equity - Investing.com India

Feb 24, 2025
pulisher
Feb 24, 2025

Eyenovia defers debt payments to bolster liquidity - Investing.com India

Feb 24, 2025
pulisher
Feb 24, 2025

Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives - The Manila Times

Feb 24, 2025
pulisher
Feb 24, 2025

Eyenovia, Inc. Announces Amendment to Senior Secured Convertible Debt to Enhance Liquidity and Support Optejet® Development - Nasdaq

Feb 24, 2025
pulisher
Feb 24, 2025

Can This Biotech's Debt Restructuring Lead to a Strategic Sale? - StockTitan

Feb 24, 2025
pulisher
Feb 11, 2025

FY2025 EPS Estimates for Eyenovia Boosted by HC Wainwright - Defense World

Feb 11, 2025
pulisher
Feb 10, 2025

Eyenovia Inc’s (EYEN) Stock: A -58.29% Simple Moving Average for the Past 20 Days - The News Heater

Feb 10, 2025
pulisher
Feb 08, 2025

Wainwright maintains neutral Eyenovia stock, $2 target - MSN

Feb 08, 2025
pulisher
Feb 06, 2025

Wainwright maintains neutral Eyenovia stock, $2 target By Investing.com - Investing.com Canada

Feb 06, 2025
pulisher
Feb 05, 2025

Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device - GlobeNewswire

Feb 05, 2025
pulisher
Feb 05, 2025

The Attractiveness of Investing In Eyenovia Inc (EYEN) is Growing - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

Eyenovia, Inc. Announces Progress on Next-Generation User-Filled Optejet Dispensing Device - Marketscreener.com

Feb 05, 2025
pulisher
Feb 05, 2025

Revolutionary Eye Drop Spray Shows Perfect Precision: Eyenovia's Game-Changing Solution for Millions - StockTitan

Feb 05, 2025
pulisher
Feb 05, 2025

Eyenovia, Inc. Advances Development of User-Filled Optejet Device for Enhanced Ophthalmic Treatment - Nasdaq

Feb 05, 2025
pulisher
Feb 01, 2025

Eyenovia enacts reverse stock split to meet Nasdaq requirements By Investing.com - Investing.com Australia

Feb 01, 2025
pulisher
Feb 01, 2025

Eyenovia enacts reverse stock split to meet Nasdaq requirements - Investing.com

Feb 01, 2025
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
大文字化:     |  ボリューム (24 時間):